IS1868B - Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess - Google Patents
Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þessInfo
- Publication number
- IS1868B IS1868B IS4168A IS4168A IS1868B IS 1868 B IS1868 B IS 1868B IS 4168 A IS4168 A IS 4168A IS 4168 A IS4168 A IS 4168A IS 1868 B IS1868 B IS 1868B
- Authority
- IS
- Iceland
- Prior art keywords
- administration
- compositions
- free base
- base form
- rectum
- Prior art date
Links
- 239000012458 free base Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000000664 rectum Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310756A GB9310756D0 (en) | 1993-05-25 | 1993-05-25 | Compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS4168A IS4168A (is) | 1994-11-26 |
| IS1868B true IS1868B (is) | 2003-05-02 |
Family
ID=10736089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4168A IS1868B (is) | 1993-05-25 | 1994-05-19 | Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US5741806A (is) |
| EP (1) | EP0700290B1 (is) |
| JP (1) | JP2965703B2 (is) |
| KR (1) | KR100297212B1 (is) |
| CN (1) | CN1106194C (is) |
| AP (1) | AP544A (is) |
| AT (1) | ATE183643T1 (is) |
| AU (1) | AU680918B2 (is) |
| BE (1) | BE1007158A3 (is) |
| BR (1) | BR1100046A (is) |
| CA (1) | CA2162919C (is) |
| CO (1) | CO4230094A1 (is) |
| CY (1) | CY2411B1 (is) |
| CZ (1) | CZ291041B6 (is) |
| DE (1) | DE69420266T2 (is) |
| DK (1) | DK0700290T3 (is) |
| EC (1) | ECSP941088A (is) |
| ES (1) | ES2136198T3 (is) |
| FR (1) | FR2705569B1 (is) |
| GB (2) | GB9310756D0 (is) |
| GR (1) | GR3031669T3 (is) |
| HR (2) | HRP940315B1 (is) |
| HU (1) | HU227121B1 (is) |
| IE (1) | IE80632B1 (is) |
| IL (1) | IL109749A (is) |
| IS (1) | IS1868B (is) |
| IT (1) | IT1272990B (is) |
| MY (1) | MY111445A (is) |
| NO (1) | NO306448B1 (is) |
| NZ (1) | NZ267415A (is) |
| PE (1) | PE13395A1 (is) |
| PL (1) | PL175578B1 (is) |
| RU (1) | RU2132684C1 (is) |
| SA (1) | SA94150003B1 (is) |
| SG (1) | SG48119A1 (is) |
| SI (1) | SI0700290T1 (is) |
| WO (1) | WO1994027599A1 (is) |
| ZA (1) | ZA943593B (is) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0102026A3 (en) | 1998-06-15 | 2002-12-28 | Sepracor Inc Marlborough | Use of optically pure (-) norcisapride for producing pharmaceutical compositions suitable for treating apnea, bulimis, and other disorders |
| EP1468685A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| EP1464333A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| SK19052000A3 (sk) | 1998-06-15 | 2001-06-11 | Sepracor, Inc. | Použitie (+)norcisapridu alebo jeho farmaceuticky prijateľnej soli, v podstate bez jeho (-)stereoizoméru na liečenie apnoe, bulímie a iných porúch |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| CA2774959C (en) * | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR920003064B1 (ko) * | 1984-01-25 | 1992-04-13 | 글락소 그룹 리미티드 | 헤테로시클릭 화합물의 제조방법 |
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| GB8627909D0 (en) * | 1986-11-21 | 1986-12-31 | Glaxo Group Ltd | Medicaments |
| GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
| GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
| US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
-
1994
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active Expired - Lifetime
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en not_active Ceased
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
-
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
-
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
-
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
-
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
-
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69423626D1 (de) | Gaserzeugende rückstandsfreie azidfreie zusammensetzung | |
| PT589843E (pt) | Composicoes farmaceuticas contendo ciclosporinas | |
| FI925615A0 (fi) | Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening | |
| FI955311A0 (fi) | Farmaseuttinen koostumuspohja | |
| FI965154L (fi) | Lääkkeen paksusuoleen kuljettava koostumus | |
| FI955812L (fi) | Siirrettävän tiedon koostumuksen säilyttäminen tukiaseman vaihdon yhteydessä | |
| FI901102A7 (fi) | Farmaseuttiset koostumukset | |
| UY24316A1 (es) | Composiciones refrescantes | |
| NO921777L (no) | Fremgangsmaate for fremstilling av isoparaffiner | |
| IT8920486A0 (it) | Composizioni farmaceutiche. | |
| NO305832B1 (no) | FremgangsmÕte for fremstilling av metanol | |
| NO900934D0 (no) | Fremgangsmaate for fremstilling av 4-substituerte piperaziner. | |
| BR9007732A (pt) | Composicao desodorante | |
| NO911122D0 (no) | Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler. | |
| IT8920068A0 (it) | Composizione deodorante. | |
| NO911606L (no) | Fremgangsmaate for fremstilling av glycidylazidpolymer. | |
| FI940219L (fi) | Nestemäisiä deodoranttikoostumuksia | |
| IS4168A (is) | Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess | |
| NO893344L (no) | Anvendelse av kopolymerer som tilsetningsmiddel for sementmoertelblandinger. | |
| BR9307800A (pt) | ComposiçÕes anticárie | |
| NO932850L (no) | Fremgangsmaate for fremstilling av staal | |
| IT1290797B1 (it) | Composizioni farmaceutiche stabilizzate | |
| FI940114L (fi) | Jauhemainen deodoranttiseos | |
| ITMI932189A0 (it) | Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta | |
| ITMI950961A0 (it) | Composizioni farmaceutiche contenenti gemfibrozil |